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Interstitial lung disease (ILD) is a unique group of lung diseases that can be associated with inﬂammatory
conditions, such as polymyositis-dermatomyositis (PM-DM). Presentation of PM-DM with ILD is not
uncommon but clinical and radiological features can be similar to other conditions (e.g. atypical pneu-
monia) and can be challenging to diagnose. Delayed diagnosis of PM-DM can be associated with
progression of pulmonary involvement and potentially increase morbidity. We report a patient pre-
senting with pulmonary symptoms who had positive anti-Jo-1 antibodies and cryptogenic organizing
pneumonia features on biopsy, which is a rare reported ﬁnding.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
There are a number of etiologies associated with interstitial
lung disease (ILD).1 ILD has been recognized as an early presen-
tation of polymyositis-dermatomyositis (PM-DM) with frequency
as high as 65%.2 ILD in PM-DM is associated with a high rate of
morbidity and mortality.2 We report a case of a patient with
dyspnea, cough, and intermittent fever in the setting of positive
anti-Jo-1 antibodies, who was subsequently documented to have
ILD on lung biopsy.2. Case report
A 52 year-old man who was previously healthy and a non-
smoker presented to an outside facility with cough, progressive
dyspnea and fevers. He was empirically treated for suspected
community acquired pneumonia with intravenous Ceftriaxone and
Levoﬂoxacin. A diagnostic bronchoscopy with bronchioalveolar
lavage sampling was unrevealing. Because of poor therapeutic
response, progression of shortness of breath, and hypoxemia, the
patient was transferred to our institution for further evaluation and
management.: þ1 507 284 0564.
teson).
-NC-ND license.The patient’s social history included a recent business trip to
Bangkok and Tokyo, but he denied any speciﬁc environmental or
infectious exposures. He denied weight loss, previous pulmonary
symptoms, muscle weakness, joints swelling and rashes. Initial
vital signs revealed that he was febrile to 38.8 C, blood pressure of
170/72 mmHg, and hypoxic with oxygen saturation in the low 80 s
on 3 liters per minute (LPM) of oxygen by nasal cannula. Physical
examination was remarkable for bilateral inspiratory crackles and
otherwise unrevealing.
Laboratory evaluation was remarkable for leukocytosis of
9.3  103/mm3 with an elevated fraction of eosinophils 0.85%
(normal 0.05e0.5%), an elevated sedimentation rate of 43 mm/1 h
(normal 0e22 mm/1 h), an elevated C-reactive protein of 21.8 mg/L
(normal  8.0 mg/L) and creatinine kinase of 740 U/L (normal 52e
336). Urine analysis was normal; no myoglobin was seen. Spirom-
etry was consistent with a restrictive pattern (FVC 38% predicted).
Repeat chest computed tomography (CT) demonstrated a progres-
sive and bilateral scattered consolidative appearing inﬁltrates
(Fig. 1). Given the recent travel and eosinophilia, an extensive
infectious disease evaluation was performed, which was
unrevealing.
A subsequent video-assisted thoracic surgery (VATS) lung
biopsy showed patchy organizing pneumonia and diffuse mixed
inﬂammatory inﬁltrates involving interstitial septa and alveolar
spaces (Fig. 2). Subsequent serologies revealed slight increase in
antinuclear antibody to 2.2 (normal < 1.0 units) with increased
anti-Jo-1 antibody of 2.2 (normal < 1.0 units); other extractable
Fig. 1. CT of the lungs shows bilateral scattered consolidative appearing inﬁltrates.
Q. Haydour et al. / Respiratory Medicine Case Reports 6 (2012) 13e1514nuclear antibodies, rheumatoid factor, and anti-neutrophil cyto-
plasmic antibodies were not detected. Due to concern for an
underlying autoimmune process, electromyography was pursued
and was consistent with a proximal inﬂammatory myopathy.
Magnetic resonance imaging of the lower extremities showed
marked intramuscular edema, which was compatible with the
clinical diagnosis of myositis. He also underwent muscle biopsy,
which showed a slight inﬂammatory myopathy and mild dener-
vation atrophy. The patient was not on any medication, including
statin therapy, that would cause myositis.
A diagnosis of anti-synthetase syndrome was made, and treat-
ment started with high dose methylprednisolone (500 mg twice
a day for three days) and cyclophosphamide (one time dose of
1000 mg IV). Subsequently, his fever, cough and breathing mark-
edly improved, with tapering of the immunosuppressive medica-
tion doses.Fig. 2. Patchy foci of conﬂuent organizing pneumonia (A: hematoxylin and eosin stain
proliferation (B: hematoxylin and eosin staining, 200). Adjacent lung with interstitial and
and areas of benign lymphoid hyperplasia (D: hematoxylin and eosin staining, 100).3. Discussion
Myositis associated with ILD may present with ILD preceding
themyositis or at any time during the disease course.3 Surgical lung
biopsies in patients with ILD associated anti-synthetase syndrome
may show different histological features including nonspeciﬁc
interstitial pneumonia (NSIP), diffuse alveolar damage (DAD), usual
interstitial pneumonia (UIP), or cryptogenic organizing pneumonia
(COP).5 The prevalence of these histological features varies between
reports.4e6
Anti-synthetase syndrome is a systemic autoimmune syndrome
characterized by the presence of anti-aminoacyl tRNA antibodies
(anti-ARS antibodies) accompanied by a constellation of clinical
ﬁndings including PM-DM, ILD, “mechanic” hands appearance and
Raynaud’s phenomenon. Anti-ARS antibodies in PM patients are
strongly associated with the presence of ILD.2,3,7 Anti-histidyl-tRNA
synthetase (anti-Jo-1) antibody was the ﬁrst of the anti-ARS anti-
bodies to be discovered and is one of the most commonly reported
auto-antibodies in patients with PM.8e10 ILD is a common early
manifestation in patients with anti-Jo-1-positive PM-DM.11 Indeed,
respiratory symptoms may be the presenting symptoms in up to
61% of patients with PM-DM.7
Previous studies have described an acute versus chronic form of
ILD associated with PM-DM. Our patient’s presenting symptoms
were respiratory in nature and the CT scan demonstrated consoli-
dation, consistent with the acute form of PM-DM associated ILD.4
Our patient’s case uniquely demonstrates how the diagnosis of
anti-synthetase syndromemay be not clinically apparent on history
or physical exam, but may appear upon further diagnostic evalua-
tion. This case also highlights the importance of considering
a broad differential diagnosis for suspected infectious pneumonia
cases that are not responding to standard antibiotic regimens.
Prompt diagnosis and appropriate therapy for those cases can
prevent disease progression and improve patient outcome.ing, 40 original magniﬁcation) characterized by intraalveolar polypoid ﬁbroblastic
intraalveolar lymphoplasmacytic inﬁltration (C: hematoxylin and eosin staining, 200)
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